Predictors of circulating INTERLEUKIN-6 levels in head and neck cancer patients

BACKGROUND: Circulating interleukin-6 (IL-6) improves outcome prediction for second primary cancer (SPC) in head and neck cancer (HNC) patients. This study aimed to identify factors associated with IL-6 serum levels in HNC patients. METHODS: This study was conducted as part of a phase III chemopreve...

Descripción completa

Detalles Bibliográficos
Autores principales: Cottin, Sylvine Carrondo, Turcotte, Stéphane, Douville, Pierre, Meyer, François, Bairati, Isabelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6017994/
https://www.ncbi.nlm.nih.gov/pubmed/29951282
http://dx.doi.org/10.1186/s41199-018-0029-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6017994/
https://www.ncbi.nlm.nih.gov/pubmed/29951282
http://dx.doi.org/10.1186/s41199-018-0029-5

Ejemplares similares